Thursday, September 28, 2017 7:21:24 PM
Other important dates...
I believe I am in sync with the dates. Corrections welcomed.
...a timeline outlining the significant procedural steps in a typical “going dark” transaction for a domestic listed company.
Day 1: 09/14/2017
The company files written notice of intent to file a Form 25 with the stock exchange pursuant to Rule 12d2-2(c)(2)(ii), issues a press release and files a Form 8-K announcing that it is delisting and “going dark,” and the reasons therefore. This information should also be placed on the company Web site.
Day 10: 09/25/2017
The company files Form 25 with the stock exchange and announces the same.
Day 11: 09/26/2017
The company stock continues trading or shortly thereafter begins trading in the OTCQB.
Has been trading as of 09/14/2017. They managed to bypass this stage per agreement between Nasdaq and OTCQB.
Day 20: 10/05/2017
The company files a Form 15 to deregister its shares under the Exchange Act. The Form 15 may not be filed prior to the effective date of the Form 25 (ten days after filing).
The company issues a press release announcing deregistration.
Day 100: 12/26/2017
Section 12(b) deregistration becomes effective.
Day 110: 01/05/2018
The 90-day period after filing of Form 15 passes making effective the deregistration of the company’s stock under Exchange Act Section 12(g) and the suspension of reporting obligations under Section 15(d), if applicable.
Note: If a filing deadline falls on a weekend or federal holiday, the due date is “adjusted” to fall on the next business day pursuant to Rule 0-3(a) under the Exchange Act. Thus, if a filing is due on a Saturday or Sunday, the issuer must instead submit the filing to the SEC via EDGAR on the next Monday before 5.30 p.m. Eastern Time.
I believe I am in sync with the dates. Corrections welcomed.
...a timeline outlining the significant procedural steps in a typical “going dark” transaction for a domestic listed company.
Day 1: 09/14/2017
The company files written notice of intent to file a Form 25 with the stock exchange pursuant to Rule 12d2-2(c)(2)(ii), issues a press release and files a Form 8-K announcing that it is delisting and “going dark,” and the reasons therefore. This information should also be placed on the company Web site.
Day 10: 09/25/2017
The company files Form 25 with the stock exchange and announces the same.
Day 11: 09/26/2017
The company stock continues trading or shortly thereafter begins trading in the OTCQB.
Has been trading as of 09/14/2017. They managed to bypass this stage per agreement between Nasdaq and OTCQB.
Day 20: 10/05/2017
The company files a Form 15 to deregister its shares under the Exchange Act. The Form 15 may not be filed prior to the effective date of the Form 25 (ten days after filing).
The company issues a press release announcing deregistration.
Day 100: 12/26/2017
Section 12(b) deregistration becomes effective.
Day 110: 01/05/2018
The 90-day period after filing of Form 15 passes making effective the deregistration of the company’s stock under Exchange Act Section 12(g) and the suspension of reporting obligations under Section 15(d), if applicable.
Note: If a filing deadline falls on a weekend or federal holiday, the due date is “adjusted” to fall on the next business day pursuant to Rule 0-3(a) under the Exchange Act. Thus, if a filing is due on a Saturday or Sunday, the issuer must instead submit the filing to the SEC via EDGAR on the next Monday before 5.30 p.m. Eastern Time.
Recent DCTH News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/27/2026 08:12:24 PM
- Delcath Systems to Host First Quarter 2026 Earnings Call • Business Wire • 04/23/2026 12:30:00 PM
- Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma • Business Wire • 04/06/2026 12:30:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/02/2026 12:56:15 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/02/2026 12:55:31 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/02/2026 12:52:52 PM
- Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting • Business Wire • 04/01/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:22:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 09:48:16 PM
- Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology • Business Wire • 03/03/2026 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 02:15:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 01:06:06 PM
- Delcath Systems Reports Fourth Quarter and Full Year 2025 Results • Business Wire • 02/26/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:30:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:30:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:30:11 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:30:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:30:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:30:05 AM
- Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call • Business Wire • 02/12/2026 01:00:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/10/2026 07:41:34 PM
- Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference • Business Wire • 01/27/2026 01:05:00 PM
- Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 01/21/2026 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 09:41:41 PM
